Abstract
Tangier disease (TD) is an autosomal recessive disorder of lipid metabolism1. It is characterized by absence of plasma high-density lipoprotein (HDL) and deposition of cholesteryl esters in the reticulo-endothelial system with splenomegaly and enlargement of tonsils and lymph nodes2. Although low HDL cholesterol is associated with an increased risk for coronary artery disease, this condition is not consistently found in TD pedigrees. Metabolic studies in TD patients have revealed a rapid catabolism of HDL and its precursors2. In contrast to normal mononuclear phagocytes (MNP), MNP from TD individuals degrade internalized HDL in unusual lysosomes, indicating a defect in cellular lipid metabolism3,4. HDL-mediated cholesterol efflux and intracellular lipid trafficking and turnover are abnormal in TD fibroblasts5,6,7, which have a reduced in vitro growth rate8. The TD locus has been mapped to chromosome 9q31 (ref. 9). Here we present evidence that TD is caused by mutations in ABC1, encoding a member of the ATP-binding cassette (ABC) transporter family, located on chromosome 9q22–31 (ref. 10). We have analysed five kindreds with TD and identified seven different mutations, including three that are expected to impair the function of the gene product. The identification of ABC1 as the TD locus has implications for the understanding of cellular HDL metabolism and reverse cholesterol transport, and its association with premature cardiovascular disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fredrickson, D.S., Altrocchi, P.H., Avioli, L.V., Goodman, D.S. & Goodman, H.C. Tangier disease—combined clinical staff conference at the National Institutes of Health. Ann. Intern. Med. 55, 1016–1031 (1961).
Assmann, G., Schmitz, G. & Brewer, H.B. Jr Familial high density lipoprotein deficiency: Tangier disease. in The Metabolic Basis of Inherited Disease (eds Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.) 1267–1282 (McGraw-Hill, New York, 1989).
Schmitz, G., Assmann, G., Robenek, H. & Brennhausen, B. Tangier disease: a disorder of intracellular membrane traffic. Proc. Natl Acad. Sci. USA 82, 6305–6309 ( 1985).
Robenek, H. & Schmitz, G. Abnormal processing of Golgi elements and lysosomes in Tangier disease. Arterioscler. Thromb. 11, 1007–1020 (1991).
Rogler, G., Trümbach, B., Klima, B., Lackner, K.J. & Schmitz, G. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients. Arterioscler. Thromb. Vasc. Biol. 15, 683– 690 (1995).
Francis, G.A., Knopp, R.H. & Oram, J.F. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J. Clin. Invest. 96, 78–87 (1995).
Schmitz, G., Fischer, H., Beuck, M., Hoecker, K.P. & Robenek, H. Dysregulation of lipid metabolism in Tangier monocyte-derived macrophages. Arteriosclerosis 10, 1010– 1019 (1990).
Drobnik, W. et al. Growth and cell cycle abnormalities of fibroblasts from Tangier disease patients. Arterioscler. Thromb. Vasc. Biol. 19, 28–38 (1999).
Rust, S. et al. Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy. Nature Genet. 20, 96–98 (1998).
Luciani, M.F., Denizot, F., Savary, S., Mattei, M.G. & Chimini, G. Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics 21, 150– 159 (1994).
Langmann, T. et al. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Comm. 257, 29– 33 (1999).
Higgins, C.F. ABC-transporters: from microorganisms to man. Annu. Rev. Cell Biol. 8, 67–113 (1992).
Higgins, C.F. Flip-flop: the transmembrane translocation of lipids. Cell 79, 393–395 (1994).
Van Helvoort, A. et al. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87, 507–517 (1996).
Dekkers, D.W., Comfurius, P., Schroit, A.J., Bevers, E.M. & Zwaal, R.F. Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: outward-directed transport by the multidrug resistance protein 1 (MRP1). Biochemistry 37, 14833–14837 (1998).
Mosser, J. et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361, 726–730 (1993).
Allikmets, R., Gerrard, B., Hutchinson, A. & Dean, M. Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database. Hum. Mol. Genet. 5, 1649–1655 (1996).
Allikmets, R. et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nature Genet. 15, 236–246 (1997).
Assmann, G., Smootz, E., Adler, K., Capurso, A. & Oette, K. The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins. J. Clin. Invest. 59, 565 –575 (1977).
Gibbels, E. et al. Severe polyneuropathy in Tangier disease mimicking syringomyelia or leprosy. Clinical, biochemical, electrophysiological, and morphological evaluation, including electron microscopy of nerve, muscle, and skin biopsies. J. Neurol. 232, 283–294 (1985).
von Eckardstein, A. et al. Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I. J. Lipid Res. 39, 987–998 (1998).
Schneider, E. & Hunke, S. ATP-binding cassette (ABC) transport systems: functional and structural aspects of the ATP-hydrolyzing subunits/domains. FEMS Microbiol. Rev. 22, 1– 20 (1998).
Ramjeesingh, M. et al. Walker mutations reveal loose relationship between catalytic and channel-gating activities of purified CFTR (cystic fibrosis transmembrane conductance regulator). Biochemistry 38, 1463–1468 (1999).
Lewis, R.A. et al. Genotype/phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, ABCR, in Stargardt disease. Am. J. Hum. Genet. 64, 422–434 (1999).
Luciani, M.F. & Chimini, G. The ATP binding cassette transporter ABC1 is required for the engulfment of corpses generated by apoptotic cell death. EMBO J. 15, 226– 235 (1996).
Hamon, Y. et al. Interleukin-1β secretion is impaired by inhibitors of the ATP binding cassette transporter, ABC1. Blood 90, 2911–2915 (1997).
Fielding, C.J. & Fielding, P.E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36, 211–228 (1995).
Acton, S. et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271, 518– 520 (1996).
Jian, B. et al. Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J. Biol. Chem. 273, 5599–5606 (1998).
Acknowledgements
We thank U. Stöckl for molecular biological assistance; R. Glätzl, S. Potra and D. Hant for technical help; G. Chimini for helpful discussions and providing Abc1-null mice; and D. Bowyer for critical reading of the manuscript. This work has been supported by a grant from Bayer AG Pharma-Research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bodzioch, M., Orsó, E., Klucken, J. et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22, 347–351 (1999). https://doi.org/10.1038/11914
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/11914
This article is cited by
-
A Simple and Low-cost Preliminary Quantification of Target Membrane Protein in Single Cells
Journal of Fluorescence (2023)
-
Insulin Downregulates the Expression of ATP-binding Cassette Transporter A-I in Human Hepatoma Cell Line HepG2 in a FOXO1 and LXR Dependent Manner
Cell Biochemistry and Biophysics (2023)
-
Cholesterol homeostasis regulated by ABCA1 is critical for retinal ganglion cell survival
Science China Life Sciences (2023)
-
The role of ATP-binding cassette subfamily A in the etiology of Alzheimer’s disease
Molecular Neurodegeneration (2022)
-
Potential Therapeutic Agents That Target ATP Binding Cassette A1 (ABCA1) Gene Expression
Drugs (2022)